CClinicalTrials.gg
Status unknownNCT01402362Updated Jul 26, 2011

Prevalence of Glucose Intolerance and Risk Factors in Ethiopian Immigrants in Israel; Follow-up Study.

An observational study in Diabetes Mellitus and Glucose Intolerance, sponsored by Hillel Yaffe Medical Center. Status unknown at 1 site in Israel. Open to participants aged 25 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-07-26.

Sponsored by Hillel Yaffe Medical Center · Observational

The sponsor has not verified this record recently (last verified Jun 2011), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
550
Ages
25 Years to 90 Years
Sex
All
01

Study summary

High risk population: Screening for impaired glucose tolerance.

02

Conditions studied

  • Diabetes Mellitus
  • Glucose Intolerance

Keywords

  • Ethiopians
  • Diabetes Mellitus
  • Glucose tolerance
  • Israel
  • Included in the year 2000 study
03

In context

Diabetes Mellitus

10,926 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's planned enrollment of 550 is above the median of 233 across 2,220 observational studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Hillel Yaffe Medical Center is the lead sponsor of 301 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Ethiopian immigrants to Israel living in Hadera.

Inclusion criteria

  • Participation in the year 2000 study
  • Signature of Informed Consent Form

Exclusion criteria

Exclusion Criteria:

Pregnancy

-

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
550 participants (estimated)

Groups and cohorts

  • Ethiopians participating in previous study, year 2000
06

What researchers measure

Primary outcomes

  1. Percent of patients with Diabetes Mellitus or impaired glucose tolerance

    Time frame: Day 1 of study

Secondary outcomes

  1. Prevalence of hypertension and hyperlipidemia

    Time frame: Day 1 of study

07

Study locations

1 site
  • Diabetes and Endocrinology Unit, Hillel Yaffe MC, POB169
    Hadera, 38100, Israel
    • Anat Jaffe, MD PhD · Contact · jaffe@hy.health.gov.il · +97246304748
    • Liana Tripto, MD · Sub investigator
    • Anat Jaffe, MD PhD · Principal investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01402362
Lead sponsor
Hillel Yaffe Medical Center
First posted
Jul 26, 2011
Start date
Sep 2011
Last update
Jul 26, 2011

Study contacts

Anat Jaffe, MD PhD
Contact
Jaffe@hy.health.gov.il
+97246304748
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion